<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Crit Care</journal-id><journal-title-group><journal-title>Critical Care</journal-title></journal-title-group><issn pub-type="ppub">1364-8535</issn><issn pub-type="epub">1466-609X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">3301210</article-id><article-id pub-id-type="publisher-id">cc5870</article-id><article-id pub-id-type="doi">10.1186/cc5870</article-id><article-categories><subj-group subj-group-type="heading"><subject>Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Intensive insulin therapy versus conventional glycemic control in patients with acute neurological injury: a prospective controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author" id="A1"><name><surname>Azevedo</surname><given-names>JR</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A2"><name><surname>Lima</surname><given-names>ERM</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A3"><name><surname>Cossetti</surname><given-names>RJD</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A4"><name><surname>Azevedo</surname><given-names>RP</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib></contrib-group><aff id="I1"><label>1</label>Hospital S&#x000e3;o Domingos, S&#x000e3;o Luiz &#x02013; MA, Brazil and Hospital Dr Clementino Moura, S&#x000e3;o Luiz &#x02013; MA, Brazil</aff><pub-date pub-type="ppub"><year>2007</year></pub-date><pub-date pub-type="epub"><day>19</day><month>6</month><year>2007</year></pub-date><volume>11</volume><issue>Suppl 3</issue><supplement><named-content content-type="supplement-title">Fourth International Symposium on Intensive Care and Emergency Medicine for Latin America</named-content><ext-link ext-link-type="uri" xlink:href="http://ccforum.com/supplements/notes/ccv11s3-info.pdf">http://ccforum.com/supplements/notes/ccv11s3-info.pdf</ext-link></supplement><fpage>P83</fpage><lpage>P83</lpage><permissions><copyright-statement>Copyright &#x000a9;2007 BioMed Central Ltd</copyright-statement><copyright-year>2007</copyright-year><copyright-holder>BioMed Central Ltd</copyright-holder></permissions><self-uri xlink:href="http://ccforum.com/content/11/S3/P83"/><conference><conf-date>20-23 June 2007</conf-date><conf-name>Fourth International Symposium on Intensive Care and Emergency Medicine for Latin America</conf-name><conf-loc>S&#x000e3;o Paulo, Brazil</conf-loc></conference></article-meta></front><body><sec><title>Objective</title><p>To compare intensive insulin therapy with conventional glycemic control in patients with acute neurological injury, evaluating neurological outcome and morbi-mortality.</p></sec><sec sec-type="methods"><title>Methods</title><p>Patients with two glycemias above 150 mg/dl 12 hours after admission were randomized to receive intensive insulin therapy (G1) or conventional treatment (G2). We evaluated a subgroup of patients with acute brain injury from July 2004 to June 2006.</p></sec><sec><title>Results</title><p>G1 patients (<italic>n </italic>= 31) received 70.5 (45.1&#x02013;87.5) units insulin/day while G2 patients (<italic>n </italic>= 19) received 2 (0.6&#x02013;14.1) units/day (<italic>P </italic>&#x0003c; 0.0001). The median glycemia was comparable in both groups (<italic>P </italic>= 0.16). Hypoglycemia occurred in two patients (6.4%) in G1 and in one patient (5.8%) in G2 (<italic>P </italic>= 1.0). Mortality in G1 was 25.8%, and it was 35.2% in G2 (relative reduction of 27%). Neurological outcome was similar in both groups.</p></sec><sec><title>Conclusion</title><p>A less strict intensive insulin therapy can reduce hypoglycemia and still maintain its benefits.</p></sec></body></article>